Clinical Trial Update: Role of IV Calcium to Prevent Diltiazem-related Hypotension [Phase 4]

View source ↗

Summary

Phase 4 trial completed evaluating whether intravenous calcium can prevent diltiazem-related hypotension in patients with atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Calcium (IV) (calcium)
• Diltiazem (diltiazem)

Snippet

Sponsor: Haseki Training and Research Hospital | Conditions: Atrial Fibrillation, Rapid Ventricular Response | Phase 4 | Status: COMPLETED